Publicacións en colaboración con investigadores/as de Hospital Universitario Puerta del Mar (21)

2024

  1. Human T-lymphotropic virus-1 infection among Latin American pregnant women living in Spain

    IJID Regions, Vol. 10, pp. 146-149

2023

  1. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

  2. HTLV infection in persons with sexually transmitted diseases in Spain

    Frontiers in Immunology, Vol. 14

  3. Longitudinal effects of FTO gene polymorphism on body composition, cardiorespiratory fitness, physical activity, inflammatory markers, and cardiovascular risk in children and adolescents. “The UP & DOWN study”

    Scandinavian Journal of Medicine and Science in Sports, Vol. 33, Núm. 11, pp. 2261-2272

2022

  1. Influence of Peroxisome Proliferator-Activated Receptor (PPAR)-gamma Coactivator (PGC)-1 alpha gene rs8192678 polymorphism by gender on different health-related parameters in healthy young adults

    Frontiers in Physiology, Vol. 13

2021

  1. Influence of ace gene I/D polymorphism on cardiometabolic risk, maximal fat oxidation, cardiorespiratory fitness, diet and physical activity in young adults

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 7

2019

  1. HTLV-1 infection in solid organ transplant donors and recipients in Spain

    BMC Infectious Diseases, Vol. 19, Núm. 1

2017

  1. Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2083-2088

2014

  1. Molecular epidemiology and clinical features of human T cell lymphotropic virus type 1 infection in Spain

    AIDS Research and Human Retroviruses, Vol. 30, Núm. 9, pp. 856-862

  2. Predictive factors of severe multilobar pneumonia and shock in patients with influenza

    Emergency Medicine Journal, Vol. 31, Núm. 4, pp. 301-307

2013

  1. Risk factors and effectiveness of preventive measures against influenza in the community

    Influenza and other Respiratory Viruses, Vol. 7, Núm. 2, pp. 177-183

2012

  1. Effectiveness of hand hygiene and provision of information in preventing influenza cases requiring hospitalization

    Preventive Medicine, Vol. 54, Núm. 6, pp. 434-439

  2. Prognosis of hospitalized patients with 2009 H1N1 influenza in Spain: Influence of neuraminidase inhibitors

    Journal of Antimicrobial Chemotherapy, Vol. 67, Núm. 7, pp. 1739-1745

  3. Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain

    Virology Journal, Vol. 9, Núm. 1

2008

  1. Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens

    HIV Clinical Trials, Vol. 9, Núm. 5, pp. 309-313

2007

  1. Infection by the type 2 human immunodeficiency virus and types 1 and 2 human lymphotropic virus in Spain

    Medicina Clinica

2005

  1. Molecular epidemiology of HTLV-2 infection among intravenous drug users in Spain

    Journal of Clinical Virology, Vol. 33, Núm. 1, pp. 65-70

2004

  1. HIV-2 and HTLV-I/II infections in Spain

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 22, Núm. 3, pp. 177-182

  2. Incidence and Predictors of Severe Liver Fibrosis in Human Immunodeficiency Virus-Infected Patients with Chronic Hepatitis C: A European Collaborative Study

    Clinical Infectious Diseases, Vol. 38, Núm. 1, pp. 128-133

2002

  1. Impact of HIV genotyping and drug levels on the response to salvage therapy with saquinavir/ritonavir

    AIDS, Vol. 16, Núm. 14, pp. 1964-1966